| 生长抑素联合乌司他丁治疗消化道出血的Meta分析 |
| |
| 引用本文： | 周嫏嬛,龚伟玲,孙孚春,宋颂. 生长抑素联合乌司他丁治疗消化道出血的Meta分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(1): 26-32. DOI: 10.3877/cma.j.issn.2095-2015.2023.01.006 |
| |
| 作者姓名： | 周嫏嬛 龚伟玲 孙孚春 宋颂 |
| |
| 作者单位： | 1. 266109 山东省，青岛市城阳区人民医院临床药学科2. 100071 北京，联勤保障部队药品仪器监督检验总站药品安全监督科 |
| |
| 摘 要： | 目的 系统评价生长抑素联合乌司他丁治疗消化道出血的有效性和安全性。方法 计算机检索中国知网、维普、万方、CBM、PubMed、Cochorane library、Embase数据库,搜集有关生长抑素联合乌司他丁治疗消化道出血的随机对照试验。使用Revman 5.3软件进行Mete分析。结果 共纳入16项研究,1466例患者。结果显示,在总有效率[RR=1.24,95%CI(1.19～1.31),P <0.000 01]、白细胞介素-2[SMD=1.10,95%CI(0.38～1.81),P=0.003]、白细胞介素-6[SMD=-3.40,95%CI(-4.69～-2.12),P <0.000 01]、白细胞介素-10[SMD=2.77,95%CI(1.66～3.87),P <0.000 01]、肿瘤坏死因子-α[SMD=-2.56,95%CI(-3.26～-1.87),P<0.000 01]、住院时间[SMD=-1.75,95%CI(-2.24～-1.26),P<0.000 01]、消化道出血时间[SMD=-3.55,95%CI(-4.11～-2.99)...
|
| 关 键 词： | 消化道出血 乌司他丁 生长抑素 Meta分析 |
| 收稿时间： | 2022-09-20 |
Meta analysis of somatostatin combined with ulinastatin in the treatment of gastrointestinal bleeding |
| |
| Langhuan Zhou,Weiling Gong,Fuchun Sun,Song Song. Meta analysis of somatostatin combined with ulinastatin in the treatment of gastrointestinal bleeding[J]. Journal of Chinese digestive disease and image (electronic version), 2023, 13(1): 26-32. DOI: 10.3877/cma.j.issn.2095-2015.2023.01.006 |
| |
| Authors: | Langhuan Zhou Weiling Gong Fuchun Sun Song Song |
| |
| Affiliation: | 1. Department of Clinical Pharmacy, Chengyang People′s Hospital of Qingdao, Qingdao 266109, China2. Department of Drug Safety Supervision, Pharmaceutical Instrument Supervision and Inspection Station, Joint Logistic Support Force, Beijing 100071, China |
| |
| Abstract: | ObjectiveTo systematically evaluate the efficacy and safety of somatostatin combined with ulinastatin in the treatment of gastrointestinal hemorrhage. MethodsCNKI, VIP, Wanfang, CBM database, PubMed, Cochrane Library, EMBase were searched to collect randomized controlled trials of somatostatin combined with ulinastatin in the treatment of gastrointestinal bleeding.Mete analysis was performed using Revman 5.3 software. ResultsA total of 16 studies involving 1466 patients were included.The results showed that somatostatin combined with ulinastatin was better than somatostatin alone in the total effective rate(RR=1.24, 95% CI: 1.19-1.31, P<0.000 01), interleukin-2(SMD=1.10, 95% CI: 0.38-1.81, P=0.003), interleukin-6(SMD=-3.40, 95% CI: -4.69--2.12, P<0.000 01), interleukin-10(SMD=2.77, 95% CI: 1.66-3.87, P<0.000 01), tumor necrosis factor-α(SMD=-2.56, 95% CI: -3.26--1.87, P<0.000 01), hospitalization time(SMD=-1.75, 95% CI: -2.24--1.26, P<0.000 01)and gastrointestinal hemostasis time(SMD=-3.55, 95% CI: -4.11--2.99, P<0.000 01). There was no statistically significant difference in the incidence of adverse reactions between the two groups(SMD=0.79, 95% CI: 0.47-1.32, P=0.38), and both were lower. ConclusionSomatostatin combined with ulinastatin in the treatment of gastrointestinal bleeding is safe and effective, but it needs more high-quality clinical trials to verify. |
| |
| Keywords: | Gastrointestinal bleeding Ulinastatin Somatostatin Meta analysis |
|
| 点击此处可从《中华消化病与影像杂志(电子版)》浏览原始摘要信息 |
|
点击此处可从《中华消化病与影像杂志(电子版)》下载全文 |
|
